
Gufic Biosciences Limited has informed the Exchange regarding a press release dated September 11, 2023, titled "Press Release Gufic receives approval of TGA, Australia and ANVISA, Brazil for Parecoxib 40mg injection ".
Filed with NSE ·

Gufic Biosciences Limited has informed the Exchange regarding a press release dated September 11, 2023, titled "Press Release Gufic receives approval of TGA, Australia and ANVISA, Brazil for Parecoxib 40mg injection ".
6ix hasn’t read this filing yet.
Gufic Biosciences Limited on 6ix
Follow Gufic Biosciences into a list and get an email when it puts out news.
Follow Gufic Biosciences